We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+8.8%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$46.2B
AUM Growth
+$1.83B
(+4.1%)
Cap. Flow
-$543M
Cap. Flow
% of AUM
-1.17%
Top 10 Holdings %
Top 10 Hldgs %
24.86%
Holding
1,809
New
24
Increased
1,140
Reduced
325
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$98M |
| 2 |
Kinder Morgan
KMI
|
+$97.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$96.6M |
| 4 |
UnitedHealth
UNH
|
+$77.5M |
| 5 |
Marriott International
MAR
|
+$58.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$198M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$179M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$162M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$154M |
| 5 |
Bank of America
BAC
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.89% |
| 2 | Healthcare | 18.49% |
| 3 | Financials | 11.85% |
| 4 | Consumer Discretionary | 9.1% |
| 5 | Industrials | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Baxter International
BAX
$12.8B
| $2.02M | ﹤0.01% |
49,773
+1,040
| +2% | +$44.1K |
|
852
Valmont Industries
VMI
$8.86B
| $2M | ﹤0.01% |
6,272
+400
| +7% | +$128K |
|
853
Federal Realty Investment Trust
FRT
$10.9B
| $2M | ﹤0.01% |
20,190
+900
| +5% | +$94.1K |
|
854
nVent Electric
NVT
$21.6B
| $1.99M | ﹤0.01% |
46,330
+2,950
| +7% | +$124K |
|
855
Simpson Manufacturing
SSD
$7.79B
| $1.99M | ﹤0.01% |
18,142
+465
| +3% | +$48.8K |
|
|
BERY
856
DELISTED
Berry Global Group, Inc.
BERY
| $1.98M | ﹤0.01% |
36,656
-7,449
| -17% | -$412K |
|
857
First Industrial Realty Trust
FR
$8.66B
| $1.98M | ﹤0.01% |
37,238
+4,500
| +14% | +$234K |
|
858
RLI Corp
RLI
$6.02B
| $1.98M | ﹤0.01% |
29,778
-4,210
| -12% | -$280K |
|
|
APLS
859
DELISTED
Apellis Pharmaceuticals
APLS
| $1.97M | ﹤0.01% |
29,930
-133,500
| -82% | -$7.7M |
|
|
MPT
860
Medical Properties Trust
MPT
$2.84B
| $1.97M | ﹤0.01% |
239,422
+55,765
| +30% | +$616K |
|
861
FTI Consulting
FCN
$5.14B
| $1.96M | ﹤0.01% |
9,927
+800
| +9% | +$139K |
|
862
Johnson Controls International
JCI
$85.1B
| $1.96M | ﹤0.01% |
32,520
+740
| +2% | +$47.4K |
|
863
Mineralys Therapeutics
MLYS
$2.32B
| $1.96M | ﹤0.01% |
+125,000
| New | +$2.1M |
|
864
Tango Therapeutics
TNGX
$4.21B
| $1.96M | ﹤0.01% |
495,213
| – | – |
|
865
Universal Display
OLED
$3.75B
| $1.95M | ﹤0.01% |
12,570
+1,900
| +18% | +$255K |
|
|
HLVX
866
DELISTED
HilleVax
HLVX
| $1.95M | ﹤0.01% |
117,746
| – | – |
|
867
Qualys
QLYS
$4.76B
| $1.94M | ﹤0.01% |
14,903
+2,141
| +17% | +$251K |
|
|
SGI
868
Somnigroup International
SGI
$14.4B
| $1.94M | ﹤0.01% |
49,028
+4,550
| +10% | +$181K |
|
869
SiriusXM
SIRI
$11B
| $1.93M | ﹤0.01% |
48,496
+26,116
| +117% | +$1.25M |
|
870
Organon & Co
OGN
$3.56B
| $1.92M | ﹤0.01% |
81,510
+3,592
| +5% | +$96.4K |
|
871
Primerica
PRI
$10.1B
| $1.91M | ﹤0.01% |
11,096
+1,500
| +16% | +$246K |
|
872
Envista
NVST
$4.62B
| $1.91M | ﹤0.01% |
46,670
+5,600
| +14% | +$213K |
|
873
Hexcel
HXL
$7.97B
| $1.9M | ﹤0.01% |
27,810
+4,300
| +18% | +$292K |
|
874
10x Genomics
TXG
$5.88B
| $1.88M | ﹤0.01% |
33,628
-42,389
| -56% | -$1.98M |
|
875
Sun Life Financial
SLF
$45.6B
| $1.87M | ﹤0.01% |
40,100
+6,200
| +18% | +$298K |
|
Similar funds
SCP
Ensign Peak Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Ensign Peak Advisors held 1,809 positions worth $46.2B, up 4.1% from $44.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 3.4%. Ensign Peak Advisors opened 24 new positions and exited 37, leaving the 1,809-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q1 2023 buy was State Street Financial Select Sector SPDR ETF: 1,117,296 shares worth $35.9M.
- Ensign Peak Advisors added most to Eli Lilly in Q1 2023, an estimated $98M increase.
- Ensign Peak Advisors's biggest Q1 2023 reduction was First Republic Bank, cutting an estimated $198M.
- Ensign Peak Advisors fully exited iShares Russell 2000 ETF in Q1 2023, selling an estimated $179M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $46.2B portfolio in Q1 2023.
- Ensign Peak Advisors opened 24 new positions and closed 37 in Q1 2023.
- Ensign Peak Advisors's portfolio value rose 4.1% quarter-over-quarter to $46.2B.
Based on Ensign Peak Advisors's 13F filing for Q1 2023, filed 15 May 2023.